IOVS Annual Reviews: Physical Science Suite
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:2107-2114.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-1092

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noda, Y.
Right arrow Articles by Ishibashi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noda, Y.
Right arrow Articles by Ishibashi, T.

Functional Properties of Hyalocytes under PDGF-Rich Conditions

Yoshihiro Noda,1 Yasuaki Hata,1 Toshio Hisatomi,1 Yuka Nakamura,1 Kumiko Hirayama,1 Muneki Miura,1 Shintaro Nakao,1 Kimihiko Fujisawa,1 Taiji Sakamoto,2 and Tatsuro Ishibashi1

1From the Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and the 2Department of Ophthalmology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.

PURPOSE. To investigate the functional properties and intracellular signaling of hyalocytes under platelet-derived growth factor (PDGF)–rich conditions.

METHODS. The hyalocytes were isolated from bovine eyes and identified by immunocytochemistry and electron microscope. The expression of PDGF receptor {alpha}/ß and its phosphorylation in response to PDGF-BB was analyzed by Western blot analysis. PDGF-BB–induced proliferation and migration were evaluated by thymidine uptake and Boyden’s chemotaxis assay. The expression of the urokinase-type plasminogen activator (uPA) gene and the fibrinolytic activity were assessed by Northern blotting and fibrin zymography. An in vitro type I collagen gel contraction assay was performed to determine the effect of PDGF-BB on cellular contraction.

RESULTS. The hyalocytes were immunocytochemically positive for S-100 and negative for glial fibrillary acidic protein (GFAP) and cytokeratin, as previously described. The electron microscope demonstrated that hyalocytes possess lysosome-like granules, mitochondria, and micropinocytotic vesicles in their cytoplasm. The hyalocytes expressed PDGF receptor {alpha} and ß, both of which were immediately phosphorylated in response to PDGF-BB. PDGF-BB also activated p85 PI3-kinase, p44/p42 mitogen-activated protein (MAP) kinase and p38 MAP kinase. PDGF-BB induced thymidine uptake and migration in a concentration-dependent (0–10 ng/mL) manner. Inhibitors of the respective kinases prohibited PDGF-BB–dependent thymidine uptake and migration with the exception of the p44/p42 MAP kinase inhibitor, which displayed no inhibitory effects on migration. PDGF-BB increased uPA gene expression and fibrinolytic activity. Collagen gel contraction observed under PDGF-BB–rich conditions was not prohibited by the respective inhibitors investigated.

CONCLUSIONS. The hyalocytes demonstrated macrophage-like characteristics and may have both physiologic and pathologic roles, such as the maintenance of vitreous transparency through fibrinolytic activity and the pathogenesis of proliferative-vitreoretinal diseases through cellular proliferation and vitreous hyper-contraction.





This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Kita, Y. Hata, R. Arita, S. Kawahara, M. Miura, S. Nakao, Y. Mochizuki, H. Enaida, Y. Goto, H. Shimokawa, et al.
Role of TGF-{beta} in proliferative vitreoretinal diseases and ROCK as a therapeutic target
PNAS, November 11, 2008; 105(45): 17504 - 17509.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
Y Hata, Y Sassa, T Kita, M Miura, K Kano, S Kawahara, R Arita, S Nakao, J L Shih, and T Ishibashi
Vascular endothelial growth factor expression by hyalocytes and its regulation by glucocorticoid
Br. J. Ophthalmol., November 1, 2008; 92(11): 1540 - 1544.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Kawahara, Y. Hata, T. Kita, R. Arita, M. Miura, S. Nakao, Y. Mochizuki, H. Enaida, T. Kagimoto, Y. Goto, et al.
Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins
Diabetes, October 1, 2008; 57(10): 2784 - 2793.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Kawahara, Y. Hata, M. Miura, T. Kita, A. Sengoku, S. Nakao, Y. Mochizuki, H. Enaida, A. Ueno, A. Hafezi-Moghadam, et al.
Intracellular Events in Retinal Glial Cells Exposed to ICG and BBG
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4426 - 4432.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Kita, Y. Hata, M. Miura, S. Kawahara, S. Nakao, and T. Ishibashi
Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells
Diabetes, May 1, 2007; 56(5): 1421 - 1428.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Kita, Y. Hata, K. Kano, M. Miura, S. Nakao, Y. Noda, H. Shimokawa, and T. Ishibashi
Transforming Growth Factor-{beta}2 and Connective Tissue Growth Factor in Proliferative Vitreoretinal Diseases: Possible Involvement of Hyalocytes and Therapeutic Potential of Rho Kinase Inhibitor
Diabetes, January 1, 2007; 56(1): 231 - 238.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Hirayama, Y. Hata, Y. Noda, M. Miura, I. Yamanaka, H. Shimokawa, and T. Ishibashi
The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by Hyalocytes
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3896 - 3903.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology